Global Antidiabetics Market Expected To Be Worth USD 80.0 Billion By 2022

In this report, the global antidiabetics market is segmented by type of insulin, product, and region. On the basis of type of insulin, the market is segmented into rapid-acting, long-acting, premixed, premixed analog, short-acting, and intermediate acting. The market on the basis of product is segmented into biguanides, thiazolodinediones, GLP-agonists, sulphonylureas, DPP-4 inhibitors, SGLT-2, alpha-glucosidase inhibitors, and meglitinides.

The global antidiabetics market size was US$ 41,305.7 million by 2013 and is projected to register a compound annual growth rate (CAGR) of more than 9.5% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/antidiabetics-market

Astra Zeneca Plc (U.K.), Boehringer Ingelheim GmbH (Germany), Eli Lilly & Co. (U.S.), Johnson & Johnson (U.S.), Mankind Pharma Ltd. (India), Merck & Co. Inc. (U.S.), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Sanofi S.A. (France), and Teva Pharmaceutical Industries Ltd. (Israel) are the most active players in the antidiabetics market.

The increasing number of diabetic patients, rising use of insulin, growing rates of obesity are expected to drive the antidiabetics market. However, stringent government regulations and loss of patent protection for antidiabetic drugs are expected to hamper the growth of the antidiabetics market.

The Anti Diabetics Market has been segmented as below:

by Types of Insulin

• Rapid Acting
• Long Acting
• Premixed
• Premixed Analog
• Short Acting
• Intermediate Acting

by Product

• Biguanides
• Thiazolodinediones
• GLP-agonists
• Sulphonylureas
• DPP-4 inhibitors
• SGLT-2
• Alpha-glucosidase Inhibitors
• Meglitinides

by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (ROW)

This report covers the antidiabetics market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global antidiabetics market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/antidiabetics-market

The deep-dive study on the antidiabetics market will help customers with the identification of new market opportunities and targeted promotional plans. The report provides global market trends, with data from 2013, estimates for 2014 and 2015, and projections of CAGRs through 2022.

Table of Contents

1. Executive Summary
2. Antidiabetics Industry Outlook
3. Antidiabetics Product Outlook
4. Antidiabetics Regional Outlook
5. Competitive Landscape
6. Company Profile
6.1 Sanofi Aventis
6.2 Takeda Pharmaceuticals
6.3 Eli Lilly
6.4 Oramed Pharmaceuticals Inc.
6.5 Merck & Co. Inc.
6.6 Novo Nordisk
6.7 Bristol-Myers Squibb
6.8 Halozyme Therapeutics
6.9 Pfizer

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.